Comparative Pharmacology
Head-to-head clinical analysis: AEROSPORIN versus OPHTHOCHLOR.
Peer-Reviewed Evidence
Head-to-head clinical analysis: AEROSPORIN versus OPHTHOCHLOR.
AEROSPORIN vs OPHTHOCHLOR
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Polymyxin B binds to the lipid A portion of bacterial lipopolysaccharides, disrupting the outer membrane permeability and causing bacterial cell death. It is primarily active against Gram-negative bacteria.
Chloramphenicol inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit, preventing peptide bond formation.
Polymyxin B sulfate: 1.5-2.5 mg/kg/day intravenously divided every 12 hours, or 25,000-30,000 units/kg/day intramuscularly divided every 12 hours. Ophthalmic: 1-2 drops in affected eye every 4 hours. Topical: Apply to affected area 3-4 times daily.
Chloramphenicol 0.5% ophthalmic solution: Instill 1-2 drops into the affected eye(s) every 3-4 hours for 7-10 days. For severe infections, every 2 hours initially. Ointment: Apply a small amount (about 0.5 cm) into the conjunctival sac every 3-4 hours.
None Documented
None Documented
Terminal elimination half-life is approximately 2-3 hours in adults with normal renal function; prolonged to 20-40 hours in severe renal impairment (CrCl <10 mL/min), necessitating dose adjustment.
5-6 hours in normal renal function; prolonged up to 24-48 hours in severe renal impairment
Primarily renal excretion of unchanged drug via glomerular filtration. Approximately 60-70% of an intravenous dose is recovered in urine within 24 hours; minimal biliary/fecal elimination (<5%).
Renal: 70-80% unchanged; biliary/fecal: 20-30%
Category C
Category C
Ophthalmic Antibiotic
Ophthalmic Antibiotic